Ullmann Financial Group Inc. purchased a new stake in shares of IBM (NYSE:IBM) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 1,997 shares of the technology company’s stock, valued at approximately $326,000.
Other hedge funds have also recently bought and sold shares of the company. ETF Managers Group LLC purchased a new stake in shares of IBM in the second quarter worth about $121,000. Price Wealth Management Inc. purchased a new stake in shares of IBM in the fourth quarter worth about $122,000. Cerebellum GP LLC purchased a new stake in shares of IBM in the fourth quarter worth about $126,000. Horan Capital Advisors LLC. purchased a new stake in shares of IBM in the third quarter worth about $136,000. Finally, Risk Paradigm Group LLC purchased a new stake in shares of IBM in the second quarter worth about $165,000. 57.02% of the stock is owned by hedge funds and other institutional investors.
Shares of NYSE IBM opened at $150.57 on Monday. IBM has a 52-week low of $139.13 and a 52-week high of $172.93. The company has a market cap of $138,700.25, a price-to-earnings ratio of 10.89, a PEG ratio of 2.20 and a beta of 0.90. The company has a debt-to-equity ratio of 2.25, a quick ratio of 1.29 and a current ratio of 1.33.
The company also recently disclosed a quarterly dividend, which was paid on Saturday, March 10th. Shareholders of record on Friday, February 9th were paid a dividend of $1.50 per share. This represents a $6.00 annualized dividend and a yield of 3.98%. The ex-dividend date of this dividend was Thursday, February 8th. IBM’s payout ratio is currently 43.48%.
Several equities research analysts have recently weighed in on the company. BMO Capital Markets reaffirmed a “hold” rating and issued a $175.00 target price on shares of IBM in a research report on Thursday, January 11th. They noted that the move was a valuation call. Bank of America reiterated a “buy” rating and issued a $200.00 price target on shares of IBM in a research note on Monday, March 26th. Zacks Investment Research upgraded IBM from a “sell” rating to a “hold” rating in a research note on Wednesday, January 10th. Royal Bank of Canada reiterated a “buy” rating and issued a $180.00 price target on shares of IBM in a research note on Friday, January 19th. Finally, JPMorgan Chase set a $167.00 price target on IBM and gave the stock a “neutral” rating in a research note on Friday, January 19th. Six investment analysts have rated the stock with a sell rating, seventeen have given a hold rating and eleven have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $166.01.
In other news, insider Erich Clementi sold 13,000 shares of the stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $154.66, for a total transaction of $2,010,580.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Diane J. Gherson sold 5,000 shares of the stock in a transaction that occurred on Monday, February 26th. The stock was sold at an average price of $156.00, for a total value of $780,000.00. Following the sale, the insider now owns 20,581 shares in the company, valued at $3,210,636. The disclosure for this sale can be found here. 0.17% of the stock is currently owned by corporate insiders.
IBM Company Profile
International Business Machines Corporation operates as an integrated technology and services company worldwide. Its Cognitive Solutions segment offers Watson, a cognitive computing platform that interacts in natural language, processes big data, and learns from interactions with people and computers.
Want to see what other hedge funds are holding IBM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IBM (NYSE:IBM).
Receive News & Ratings for IBM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IBM and related companies with MarketBeat.com's FREE daily email newsletter.